Rashed Wafaa M, Zekri Wael, Awad Madiha, Taha Hala, Abdalla Badr, Alfaar Ahmad S
*Research Department ‡Pediatric Oncology Department ∥Pathology Department, Children's Cancer Hospital Egypt §National Cancer Institute, Cairo University ¶Cairo University Hospitals †Armed Forces College of Medicine-Egypt (AFCM), Cairo, Egypt #Charité-Universitätsmedizin Berlin, Berlin, Germany.
J Pediatr Hematol Oncol. 2017 Mar;39(2):150-152. doi: 10.1097/MPH.0000000000000699.
Childhood adrenocortical carcinoma (ACC) is a rare tumor and its association with acute lymphoblastic leukemia (ALL) is even rarer. One such case is discussed in this case report. A 3-year-old patient was concomitantly diagnosed with ALL and an initially nonmetastatic ACC. Management started by following the Total XV protocol without a window phase. Left adrenalectomy was conducted after the consolidation phase. Recurrence of a mass at the tumor bed was discovered at week 33 of the continuation phase. Reexcision was conducted, followed by the administration of an ACC protocol including cisplatin, etoposide, and doxirubicin. Mitotane was added when a pulmonary metastasis was discovered and then stopped after the patient suffered from an arachnoid cyst and speech difficulties. The ALL protocol was resumed from week 34 of the continuation phase. Progression of pulmonary nodules was noted after week 45. A pulmonary metastectomy was performed. The ALL protocol was resumed up to week 51 with a good response as proven by assessment of minimal residual disease. A further recurrence was diagnosed at the abdominal tumor bed with a paravertebral mass and a pulmonary nodule. The patient was assigned to palliative treatment and died after a 32-month survival. Such rare associations need more extensive discussions of the best possible management in scientific literature.
儿童肾上腺皮质癌(ACC)是一种罕见肿瘤,其与急性淋巴细胞白血病(ALL)的关联更为罕见。本病例报告讨论了这样一例病例。一名3岁患者同时被诊断为ALL和最初无转移的ACC。治疗从遵循Total XV方案开始,无观察期。巩固期后进行了左肾上腺切除术。在延续期第33周时发现肿瘤床处有肿物复发。进行了再次切除,随后给予包括顺铂、依托泊苷和阿霉素的ACC方案。发现肺转移后加用米托坦,之后患者出现蛛网膜囊肿和言语困难,遂停用米托坦。从延续期第34周起恢复ALL方案。第45周后发现肺结节进展。进行了肺转移瘤切除术。截至第51周恢复ALL方案,微小残留病评估证明反应良好。在腹部肿瘤床处诊断出进一步复发,伴有椎旁肿物和肺结节。该患者接受姑息治疗,存活32个月后死亡。此类罕见关联需要科学文献中对最佳治疗方案进行更广泛的讨论。